Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Details Textual)

v3.3.1.900
Basis of Presentation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
May. 15, 2015
Jan. 25, 2016
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Jun. 30, 2014
Basis of Presentation [Line Items]            
Accumulated deficit     $ (51,878)   $ (47,827)  
Net Cash Used in Operating Activities     (2,814) $ (2,193)    
Cash and Cash Equivalents, at Carrying Value, Total     $ 6,732 $ 7,363 $ 9,494 $ 3,590
Common Stock, Par or Stated Value Per Share     $ 0.001   $ 0.001  
Class Of Warrants Or Rights Exercised     120,000      
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.53   $ 1.38  
Subsequent Event [Member] | Stockholders [Member]            
Basis of Presentation [Line Items]            
Stock Issued During Period, Shares, Other   6,500,000        
Aspire Capital Fund Llc [Member]            
Basis of Presentation [Line Items]            
Stock Issued During Period, Shares, Other 200,000          
Aspire Capital Fund Llc [Member] | Maximum [Member]            
Basis of Presentation [Line Items]            
Sale of Stock, Consideration Received on Transaction $ 15,000          
iBio CMO [Member] | Eastern [Member]            
Basis of Presentation [Line Items]            
Stock Issued During Period, Shares, Acquisitions     10,000,000      
Common Stock, Par or Stated Value Per Share     $ 0.622      
iBio CMO [Member] | Subsequent Event [Member] | Eastern [Member]            
Basis of Presentation [Line Items]            
Stock Issued During Period, Shares, New Issues   3,500,000        
Stock Issued During Period, Shares, Acquisitions   3,500,000        
Class Of Warrants Or Rights Exercised   1,784,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.53        
Proceeds From Capitalization Received   $ 15,000        
Stock Issued During Period, Value, Acquisitions   $ 3,100